期刊文献+

霉酚酸酯与环磷酰胺冲击治疗狼疮性肾炎临床疗效的比较 被引量:37

Clinical study of mycophenolate mofetil therapy versus intermittent cyclophosphamide pulse treatment in lupus nephritis
原文传递
导出
摘要 目的 比较霉酚酸酯(MMF)与间断性环磷酚胺静脉冲击疗法(CTX)治疗狼疮肾炎(LN)的近期及远期疗效、不良反应及安全性。方法A组:间断性环磷酞胺冲击疗法治疗30例LN患者,平均随访(1865±6.10)(6~24)月. B组:MMF联合激素治疗LN患者,平均随访(21.89±7. 48)(6~48)月.两组患者的病理类型、病情基本相似,但 B组(MMF)绝大部分为皮质激素联合 CTX治疗无效者,B组患者病程明显较A组长。结果CTX组、MMF组治疗LN均能降低蛋白尿和血尿,改善肾功能及免疫指标,两组间差异无显著性意义。MMF组患者的平均疗程较CTX组明显延长,而疗效却基本相同 .不良反应:MMF组无肝功能受累、性腺抑制副反应,感染率为 13.3%。CTX组感染率为 23.3%.肝功能受累为 23.3%,性腺抑制为 28%.结论 CTX、MMF都能有效的控制狼疮肾炎,改善肾功能,两者无显著性差异.对病程长、激素联合CTX无效及病情迁延者,经MMF治疗后达到与CTX组同样效果,而且副作用少,提示MMF具有一定的优越性。 Objective To evaluate the therapeutic effect and side-effect between pulse cyclophosphamide (CTX) therapy and mycophenolate mofetil(MMF) in lupus nephritis. Methods A group (CTX group): 30 patients were given intravenous cyclophosphamide (0.5 -0.75 g/m^2) pulse plus oral prednisone. All patients were treated for (18. 65 ±6. 10) (6 -24) months. B group (MMF group): 30 patients were given MMF at a dosage of 1. 0 -1. 5 g/d and oral prednisone. All patients were treated for (21. 89±7. 48) (6-48) months. Patients in two groups were comparable in age, sex distribution, severity of renal damage. Most patients in B group were refractory to cyclophosphamide therapy, and their histories were much longer than those of A group. Results CTX and MMF both reduced proteinuria and hematuria, and improved renal function and immune indexes CTX and MMF were effective on inhibiton of autoantibodies production. The mean therapeutic period of B group was significantly longer than that of A group, but the ontcome of two groups was similar. Liver toxicity and amenorrhea were not observed, while infections(13. 3% ), herpes zoster(6. 7% ), leukopenia(3. 3% ) were found during MMF treatment. And in CTX group, liver toxicity(23. 3% ), amenorrhea(28% ), infections(23. 3% ), herpes zoster( 10% ), leukopenia (10% ) occurred. Conclusion For the treatment of lupus nephritis, the combination of mycophenolate mofetil and prednisone is as effective as the regimen of cyclophosphamide and prednisone but less toxicity.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2002年第1期21-24,共4页 Chinese Journal of Nephrology
关键词 环磷酰胺 霉酚酸酯 狼疮肾炎 治疗 疗效 Mycophenolate mofetil Cyclophosphamide Lupus nephritis
  • 相关文献

参考文献9

  • 1Austin HA. Therapy of lupus nephritis: controlled trial of prednisone and cytoxic drugs. New Engl J Med, 1986, 314:614-619.
  • 2Vasquez S, Kavanaugh AF, Schneider NR, et al. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents. J Rheumatol,1992, 19: 1625.
  • 3Glicklich D, Acharya A. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Am J Kidney Dis, 1998, 32: 318-322.
  • 4陈楠,任红,张文,俞海瑾,徐耀文,郝翠兰,傅秀兰.新型免疫抑制剂霉酚酸酯治疗狼疮性肾炎[J].上海医学,2001,24(2):81-84. 被引量:25
  • 5Chan TM, Li FK, Tang CS, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med, 2000,343: 1156-1162.
  • 6胡伟新,陈惠萍,唐政,王庆文,沈克勤,刘志红,黎磊石.霉酚酸酯与间断环磷酰胺冲击疗法治疗Ⅳ型狼疮性肾炎疗效的比较[J].肾脏病与透析肾移植杂志,2000,9(1):3-8. 被引量:97
  • 7Cameron JS. Lupus nephritis. J Am Soc Nephrol, 1999, 10: 413.
  • 8Dooley MA, Cosio FG, Patrick H, et al. Mycophenolate mofetiltherapy in lupus nephritis: clinical observations. J Am Soc Nephrol, 1999, 10: 833-839.
  • 9Layne D. Non-transplant uses of mycophenolate mofetil. Curr Opin Nephrol Hypertens, 1999, 8: 563.

二级参考文献11

共引文献119

同被引文献238

引证文献37

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部